id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-P-0630-0011,FDA,FDA-2010-P-0630,FDA/CDER Response to Heyl Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Letter,Other,Letter(s),2011-08-24T04:00:00Z,2011,8,2011-08-24T04:00:00Z,,2012-05-09T22:40:57Z,,0,0,0900006480eeb794
FDA-2010-P-0630-0010,FDA,FDA-2010-P-0630,"Determination That PENTETATE ZINC TRISODIUM (Zinc Trisodium Diethylenetriaminepentaacetate) Solution for Intravenous or Inhalation Administration, Equivalent to 1 Gram Base/5 Milliliters (Equivalent to 200 Milligrams Base/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,General Notice,2011-08-19T04:00:00Z,2011,8,,,2012-05-09T22:35:44Z,2011-21245,0,0,0900006480ee5641